Tag: Paragraph IV certification

FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage

FDA's 180-day exclusivity gives the first generic drug applicant a legal edge to launch without competition-but loopholes let companies delay entry. Here's how it works, who benefits, and why reform is urgent.